These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27784557)

  • 1. Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review.
    Trost L; Saitz TR; Hellstrom WJ
    Sex Med Rev; 2013 May; 1(1):24-41. PubMed ID: 27784557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-alpha reductase inhibitors and erectile dysfunction: the connection.
    Erdemir F; Harbin A; Hellstrom WJ
    J Sex Med; 2008 Dec; 5(12):2917-24. PubMed ID: 19090946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
    Liu L; Zhao S; Li F; Li E; Kang R; Luo L; Luo J; Wan S; Zhao Z
    J Sex Med; 2016 Sep; 13(9):1297-1310. PubMed ID: 27475241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the federal adverse events reporting system data on adverse effects of 5-alpha reductase inhibitors.
    Harrell MB; Ho K; Te AE; Kaplan SA; Chughtai B
    World J Urol; 2021 Apr; 39(4):1233-1239. PubMed ID: 32596745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ; Miner M
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
    Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
    J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.
    Gur S; Kadowitz PJ; Hellstrom WJ
    Expert Opin Drug Saf; 2013 Jan; 12(1):81-90. PubMed ID: 23173718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
    Coskuner ER; Ozkan B; Culha MG
    Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
    Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE
    Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia.
    Hagberg KW; Divan HA; Fang SC; Nickel JC; Jick SS
    Clin Epidemiol; 2017; 9():83-91. PubMed ID: 28228662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia.
    Shin YS; Karna KK; Choi BR; Park JK
    World J Mens Health; 2019 May; 37(2):157-165. PubMed ID: 30209896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.
    Fang Q; Chen P; Du N; Nandakumar KS
    Clin Breast Cancer; 2019 Oct; 19(5):e624-e636. PubMed ID: 31126837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
    Deng T; Duan X; He Z; Zhao Z; Zeng G
    Urol J; 2020 Aug; 18(2):144-150. PubMed ID: 32869255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-alpha reductase inhibitors: new insights on benefits and harms.
    Lee JY; Cho KS
    Curr Opin Urol; 2018 May; 28(3):288-293. PubMed ID: 29528971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5α-Reductase Inhibitors (5ARIs) and Male Reproduction.
    Drobnis EZ; Nangia AK
    Adv Exp Med Biol; 2017; 1034():59-61. PubMed ID: 29256127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.
    Andriole G; Bostwick D; Civantos F; Epstein J; Lucia MS; McConnell J; Roehrborn CG
    J Urol; 2005 Dec; 174(6):2098-104. PubMed ID: 16280736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia.
    Khera M; Than JK; Anaissie J; Antar A; Song W; Losso B; Pastuszak A; Kohn T; Mirabal JR
    Transl Androl Urol; 2020 Jun; 9(3):1201-1209. PubMed ID: 32676403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.
    Dörsam J; Altwein J
    Prostate Cancer Prostatic Dis; 2009; 12(2):130-6. PubMed ID: 19030020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.